ketamine has been researched along with Axonotmesis in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketamine is an anesthetic and analgesic emerging as a novel therapy for a number of clinical entities in recent years, including refractory pain, depression, and drug-induced hyperalgesia due to newly discovered mechanisms of action and new application of its known pharmacodynamics." | 2.55 | In Vogue: Ketamine for Neuroprotection in Acute Neurologic Injury. ( Bell, JD, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, JD | 1 |
| Himmelseher, S | 1 |
| Durieux, ME | 1 |
2 reviews available for ketamine and Axonotmesis
| Article | Year |
|---|---|
In Vogue: Ketamine for Neuroprotection in Acute Neurologic Injury.
Topics: Analgesics; Animals; Apoptosis; Humans; Ketamine; Neuroprotection; Neuroprotective Agents; Thrombosi | 2017 |
Revising a dogma: ketamine for patients with neurological injury?
Topics: Anesthetics, Dissociative; Cerebrovascular Circulation; Critical Care; Excitatory Amino Acid Antagon | 2005 |